Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukaemia

Singapore Medical Journal

Volumn 44, Issue 10, 2003, Pages 517-520

  Ariffin, Hany ^a   Chen, S P ^a   Wong, H L ^a   Yeoh, A ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Acute lymphoblastic leukaemia; Multiplex; Risk stratification; RT PCR

Indexed keywords

BCR ABL PROTEIN; E2A PBX1 PROTEIN; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL AF4 PROTEIN; TEL AML1 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER RISK; CANCER SCREENING; CHILD; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE FUSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; METAPHASE; MULTIPLEX REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ONCOGENE; PROGNOSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 2442459591     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14:18-24.
2. Pui CH. Childhood leukaemias. N Engl J Med 1995; 332:1618-30.
3. Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive childhood leukemia: clinical and cytogenetic characteristics and treatment outcome. A Paediatric Oncology Group study. Blood 1990; 76:489-94.
4. Raimondi SC, Behm FG, Robertson PK, et al. Cytogenetics of pre-B cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990; 8:1380-8.
5. Pui CH, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 1991;77:440-7.
6. Chessells JM, Harrison CJ, Watson SL, Vora AJ, Richards SM. Treatment of infants with acute lymphoblastic leukemia: results of the UK Infant Protocols 1987-99. Br J Haematol 2002; 117(2):306-14.
7. Shurtleff SA, Buijs A, Behm FG, et al. TEL-AMLI fusion resulting from a cryptic t(12;21) is the most common genetic lesion in paediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9:1985-9.
8. McLean TW, Ringold S, Neuberg D, et al. TEL/AML1 dimerizes and is associated with a favourable outcome in childhood acute lymphoblastic leukemia. Blood 1996; 88:4252-8.
9. Rubnitz JE, Downing JR, Pui CH, et al. TEL gene rearrangement in acute lymphoblastic leukemia: a genetic marker with prognostic significance. J Clin Oncol 1997; 15:1150-7.
10. Martinez-Climet JA. Molecular cytogenetics of childhood hematological malignancies. Leukemia 1997; 11:1999-2021.
11. Kobayashi H, Rowley JD. Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization. Genes Chromosomes Cancer 1995; 12:66-9.
12. Romano SP, Mauchaffe M, LeConiat M, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85:3662-70.
13. Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P. Multiples reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92(2):574-88.
14. Uphoff CC, Macleod RA, Denkmann SA, et al. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human B-lineage leukemia cell lines. Leukemia 1997; 11:441-7.
15. Strong RC, Korsemeyer SJ, Parkin JL, et al. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985; 65:21-31.
16. Lozzio CB, Lozzio BB. Human chorionic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45:321-34.
17. Wells SJ, Phillips CN, Farhi DC. Detection of BCRab1 in acute leukemia by molecular and cytogenetic methods. Mol Diagn 1996; 1(4):305-13.
18. Barker PE, Carroll AJ, Cooper MD. t(1;19)(q23;p13) in pre-B acute lymphoblastic leukemia cell line 697. Cancer Genet Cytogenet 1987; 25:379-80.
19. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL60) from a patient with acute promyelocytic leukaemia. Blood 1979; 54:713-33.
20. Felix CA, Lange BJ, Chessells JM. Pediatric Acute Lymphoblastic Leukemia: challenges and controversies in 2000. Hematology 2000; 285-302.
21. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vieti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ. Poor prognosis of children with Pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13). A Pediatric Oncology Group Study. Blood 1990; 76:117.
22. Lampert F, Harbott J, Ritterbach J, Schellong G, Ritter J, Creutzig U, Riehm H, Rieter A. Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy. Cancer Genet Cytogenet 1991; 54:277.
23. Fletcher JA, Lynch EA, Kimball VM, Donnelly M, Tantravahi R, Sallan SE. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77:435-9.
24. Arico M, Valsecchi M, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia. N Eng J Med 2000; 342:998-1006.